Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $666.0800 (1.84%) ($666.0800 - $666.0800) on Thu. Dec. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.85% (three month average) | RSI | 54 | Latest Price | $666.0800(1.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) DIA(40%) XLV(40%) IWD(39%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.925% in a week (0% probabilities). VIXM(-20%) TBT(-9%) UUP(-8%) VXX(-4%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.925% (StdDev 1.85%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $641.95(3.76%) | 10 Day Moving Average | $641.1(3.9%) | 20 Day Moving Average | $642.54(3.66%) | To recent high | 0% | To recent low | 22.7% | Market Cap | $70.624b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |